Meridian bioscience stock.
Jan 31, 2023 · The estimated Net Worth of James M. Anderson is at least 1.07 百万$ dollars as of 6 January 2023. Mr. Anderson owns over 8,500 units of Meridian Bioscience stock worth over 958,769$ and over the last 14 years he sold VIVO stock worth over 0$. In addition, he makes 114,667$ as Independent Director at Meridian Bioscience.
Private Equity-Backed. Primary Industry. Diagnostic Equipment. Other Industries. Biotechnology. Former Stock Listing. VIVO. Primary Office. 3471 River Hills ...The latest closing stock price for Meridian Bioscience on January 30, 2023 is 33.97. The all-time high Meridian Bioscience closing stock price was 33.97 on January 30, 2023. …7 juil. 2022 ... ... Meridian Bioscience Inc., a Nas. ... stock price on the day before the consortium's first offer before ...Meridian Bioscience is committed to working with and providing reasonable accommodation to individuals with physical and mental disabilities. If you need special assistance or an accommodation while seeking employment, please email [email protected] or call 513-271-3700. We will make a …CINCINNATI, Nov. 28, 2023 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, has been awarded the distinguished ...
Meridian to be acquired by SD Biosensor, SJL Partners for $1.53B. A high-level overview of Meridian Bioscience, Inc. (VIVO) stock. Stay up to date on the latest …Oct 29, 2023 · Show More Job Functions Find Salaries by Job Title at Meridian Bioscience. 132 Salaries (for 79 job titles) • Updated Oct 29, 2023. How much do Meridian Bioscience employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, …
Stock Meridian Bioscience, Inc. - Deutsche Boerse AG. Meridian Bioscience, Inc. (MR4.FRA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for …
Company profile page for Meridian Bioscience Inc including stock price, company news, press releases, executives, board members, and contact information.Oct 11, 2022 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... ... Meridian Bioscience, Inc. Meridian is a fully ... Meridian's shares are traded on the NASDAQ Global Select Market, symbol VIVO.May 9, 2021 · The stock of Meridian Bioscience (NAS:VIVO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation. Meridian Bioscience hits 52-week high; stock up 36% YTD SA News Wed, Jun. 08, 2022 2 Comments. Meridian Biosciences says its qPCR mixes can be used in monkeypox molecular tests
Mr. Phillips VIVO stock SEC Form 4 insiders trading. David has made over 8 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 7,500 units of VIVO stock worth $139,050 on 12 January 2022.. The largest trade he's ever made was buying 10,000 units of Meridian …
Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...
2 Mei 2022 ... One of Cincinnati's largest public companies names new C-suite member · This Cincinnati company was most popular pick in annual stock contest.Jan 31, 2023 · John Rice owns over 27,205 units of Meridian Bioscience stock worth over $1,389,950 and over the last 6 years he sold VIVO stock worth over $0. In addition, he makes $103,000 as Independent Director at Meridian Bioscience. Wallmine is a radically better financial terminal. Sign up in seconds, it's free!Meridian Bioscience Inc stock price live 33.97, this page displays NASDAQ VIVO stock exchange data. View the VIVO premarket stock price ahead of the market session or …Meridian Bioscience announced July 7 it's entered into a definitive merger agreement to be acquired by a pair of South Korean-based firms, SD Biosensor and SJL Partners, in a deal valued at $1.53 ...Meridian’s stock soared 79% during that fiscal year. Newtown-based Meridian, founded in 1977, is Greater Cincinnati’s 16th-largest public company, …The illumipro-10™ is an automated isothermal amplification and detection system for use with Meridian Bioscience, Inc. ... All items in stock and available ...
That represents a 32% premium to Meridian’s closing stock price of $25.67 on March 17, when SD Biosensor and SJL Partners made their first offer. Under the agreement, SD Biosensor will own 60% ...Oct 10, 2017 · l28988ae10vk.htm MERIDIAN BIOSCIENCE, INC. 10-K. MERIDEIAN BIOSCIENCE, INC. 10-K. Washington, D.C. 20549. FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2007.Meridian Bioscience is the IBD 50 Stocks To Watch pick for Wednesday as it eyes a new buy point and is forming a bullish base. It comes after VIVO stock ran as much as 456% above its 2020 lows. X ...CINCINNATI, Dec. 12, 2022 /PRNewswire/ — Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has entered into a side letter with the buyer, setting the closing date of Meridian’s pending merger for January 31, 2023.6 fév. 2023 ... LLP advised SD Biosensor and SJL Partners in their acquisition of Meridian Bioscience, Inc ... Meridian stock will no longer be traded on the ...
Why Meridian Bioscience Stock Shot Up Nearly 13% Today. The coronavirus-focused stock rises notably on news of yet another partnership with a diagnostics company.Dec 19, 2022 · The estimated Net Worth of Bryan T Baldasare is at least $2.96 Million dollars as of 8 February 2021. Mr. Baldasare owns over 6,254 units of Meridian Bioscience stock worth over $1,906,668 and over the last 4 years he sold VIVO stock worth over $566,813. In addition, he makes $490,759 as Chief Financial Officer, Senior Vice …
28 août 2021 ... Get the latest news and market analysis for Meridian Bioscience, Inc. (VIVO). Stay up-to-date on VIVO Stock price and share price with ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.6 fév. 2023 ... LLP advised SD Biosensor and SJL Partners in their acquisition of Meridian Bioscience, Inc ... Meridian stock will no longer be traded on the ...Aug 6, 2014 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... Diagnostic testing solutions provider Meridian Bioscience, Inc. (), recently announced that it has entered into a definitive agreement to acquire Otsuka America Pharmaceutical’s North American BreathTek business for $20 million.The deal is likely to close in Meridian’s fiscal fourth quarter. Following the news release, shares of the company gained 2.4% in …Dec 13, 2022 · Summary. Meridian Biosciences released an update saying it set the closing date for its merger on Jan. 31. The stated reason is that the acquiring parties wanted some extra time to get the financing. Meridian Bioscience is the IBD 50 Stocks To Watch pick for Wednesday as it eyes a new buy point and is forming a bullish base. It comes after VIVO stock ran as much as 456% above its 2020 lows. X ...
Historical PS ratio values for Meridian Bioscience Inc. (VIVO) over the last 10 years. The current P/S ratio for Meridian Bioscience Inc. as of November 29, 2023 is . For more information on how our historical price data is adjusted see the -calculation'>Stock Price Adjustment Guide</a>.
Find contact information for Meridian Bioscience. Learn about their Medical Devices & Equipment, Manufacturing market share, competitors, and Meridian Bioscience's email format. Company Overview. ... Stock Symbol. NASDAQ: VIVO. Meridian Bioscience Executive Team & Key Decision Makers. Name & Title Social Contact Info; Lourdes …
Maksim Labkouski. Meridian Bioscience (NASDAQ:VIVO) rose 8% after it said its planned sale to SD Biosensor, SJL Partners, is expected to close on Jan. 31.Meridian and the buyer group agreed to ...The latest closing stock price for Meridian Bioscience on January 30, 2023 is 33.97. The all-time high Meridian Bioscience closing stock price was 33.97 on January 30, 2023. …Jan 31, 2023 · About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products. Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...VIVO | Complete Vivo Collaboration Solutions Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Historical PS ratio values for Meridian Bioscience Inc. (VIVO) over the last 10 years. The current P/S ratio for Meridian Bioscience Inc. as of November 29, 2023 is . For more information on how our historical price data is adjusted see the -calculation'>Stock Price Adjustment Guide</a>.Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products.Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...
Oct 10, 2017 · l28988ae10vk.htm MERIDIAN BIOSCIENCE, INC. 10-K. MERIDEIAN BIOSCIENCE, INC. 10-K. Washington, D.C. 20549. FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2007.The historical data and Price History for Meridian Bioscience (VIVO) with Intraday, Daily, Weekly, Monthly, ... (such as a Stock or ETF Screener) where you see more than 1000 rows of data, the download will be limited to only the first 1000 records on the table. For other static pages (such as the Russell 3000 Components list) ...Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least $365 ezer dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over $261,569 and over the last 8 years she sold VIVO stock worth over $0. In addition, she makes $103,333 as Independent Director at Meridian Bioscience.Interactive Chart. Interactive Charts provide the most advanced and flexible platform for analyzing historical data, with over 100 customizable studies, drawing tools, custom spreads and expressions, plus a wide range of visualization tools. While logged into the site, you will see continuous streaming updates to the chart.Instagram:https://instagram. best health insurance marylandus bank stockspnovandf Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com. Meridian Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] 6, 2014 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... prediction of silver pricescallinex Mr. Anderson VIVO stock SEC Form 4 insiders trading. James has made over 3 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 8,500 units of VIVO stock worth $173,230 on 6 January 2023.. The largest trade he's ever made was buying 10,000 units of Meridian …8 Jul 2022 ... That represents a 32% premium to Meridian's closing stock price of ... “We are pleased to be a family with Meridian Bioscience as a great ... webull vs etrade Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ...SD BioSensor, Inc (KOSE:A137310) (SDB) and SJL Partners completed the acquisition of Meridian Bioscience, Inc. (NasdaqGS:VIVO) from Impactive Capital LP, …Dec 1, 2023 · Susan D. Rolih is the Consultant at Meridian Bioscience. Markets; Tools Portfolios. Track performance, allocation, dividends, and risks. Search SEC filings. Annotate, download XLSX & look up similar tables. Stock screener. Filter, compare, and track stocks. Insiders trading. See how executives trade. Heat map. Visualize ...